Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatorybpc-157tb-500ghk-cunsw-healthgray-market

NSW Health logs 1180 emergency presentations tied to unapproved peptides

Monthly presentations rose from five in July 2025 to almost 220 in September 2026, with BPC-157, GHK-Cu, TB-500, retatrutide and CJC-1295 named by health authorities.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 18 21:22 ETSource: RNZ

The wire

  1. 01NSW Health data covering July 2025 to September 2026 counts 1180 emergency department presentations after use of unapproved peptides sold as wellness products, with monthly cases rising from five to roughly 220.
  2. 02Health Minister Ryan Park cited liver and kidney damage, allergic reactions and severe vomiting, and said the issue will likely go to health ministers in coming months; patients are told to use only prescribed, TGA-approved products.
  3. 03RACGP's Tim Jones said products often lack listed ingredients or carry vastly different doses, reported patients as young as 14 ordering online, and warned the figures may be the tip of the iceberg given delayed effects.

From the source

NSW health authorities issue unapproved peptide use warning after hospitalisation surge

A surge in hospitalisations related to the use of unapproved peptides promoted as "wellness" products has prompted a warning from NSW health authorities.

Read at rnz.co.nz
PeptiPrescribed peptides from $99/moSee all →